Chemical Compound
(2R)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; (+)-(2R)-Naringenin; (+)-Naringenin; (2R)-5,7-Dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one; (2R)-5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; (2R)-Naringenin; (R)-5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
CAS Registry Number
17654-19-2
Primary record
(2R)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; (+)-(2R)-Naringenin; (+)-Naringenin; (2R)-5,7-Dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one; (2R)-5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; (2R)-Naringenin; (R)-5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
- 库存
- 6,571 克
- 纯度
- 99.0 %
- CAS
- 17654-19-2
化合物标识与属性
- CAS
- 17654-19-2
- PubChem CID
- 667495
- SMILES
- C1[C@@H](OC2=CC(=CC(=C2C1=O)O)O)C3=CC=C(C=C3)O
- Canonical SMILES
- O=C1C[C@H](c2ccc(O)cc2)Oc2cc(O)cc(O)c21
名称与同义词
- naringenin
- (R)-naringenin
- (2R)-naringenin
- R-naringenin
- naringetol
- salipurpol
- Naringenine
- Salipurol
- (S)-Naringenin
- (+)-naringenin
- (-)-Naringenin
- NARIGENIN
- AC1LDI7C
- RefChem:934922
- GlyTouCan:G58144EF
- 17654-19-2
- UNII-HN5425SBF2
- 5,7,4'-Trihydroxyflavanone
- CHEBI:50201
- MFCD03265520
- (R)-5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
- CCRIS 5839
- ZINC1785
- C15H12O5
- SCHEMBL17166263
- (2R)-5,7,4'-trihydroxyflavone
- HMS3468H18
- (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-4H-chromen-4-one
- (2R)-4',5,7-trihydroxyflavanone
- ALBB-015405
- G58144EF
- EINECS 207-550-2
- BBL010488
- CID667495
- EBC-03806
- NSC 11855
- NSC 34875
- STK801623
- AKOS004119880
- C15-H12-O5
- (2R)-4',5,7-trihydroxyflavan-4-one
- 480-41-1
- AJ-08090
- DEC-9-EN-1-YL UNDEC-10-ENOATE
- SC-85987
- VS-02527
- ZB000410
- AI3-23355
- J598.561G
- (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one
- BB 0261506
- CS-0207596
- N1370
- R-2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-Benzopyran-4-one
- R6691
- ST24036200
- E82461
- (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-4-one
- EN300-7380656
- 5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
- (+)-(2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
- (S)-5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
- 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone
- Q27121979
- (2R)-5,7-dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
- (S)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone
- 4H-1-benzopyran-4-one, 2,3-dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-, (2R)-
- (R)-2,3-Dihydro-2-(4-hydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one
- (R)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
- (S)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
- 2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one
- (2R)-2beta-(4-Hydroxyphenyl)-5,7-dihydroxy-2,3-dihydro-4H-1-benzopyran-4-one
- (2R)-2,3-Dihydro-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one; (+)-(2R)-Naringenin; (+)-Naringenin; (2R)-5,7-Dihydroxy-2-(4-hydroxyphenyl)-2,3-dihydrochromen-4-one; (2R)-5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one; (2R)-Naringenin; (R)-5,7-Dihydroxy-2-(4-hydroxyphenyl)chroman-4-one
- 67604-48-2
- CWE